Shares of CRH Medical Corp (NASDAQ:CRHM) rose 8.5% on Thursday . The stock traded as high as $4.13 and last traded at $4.10, with a volume of 72,705 shares changing hands. The stock had previously closed at $3.78.

CRHM has been the topic of several recent analyst reports. Canaccord Genuity reiterated a “buy” rating on shares of CRH Medical Corp in a report on Monday, July 11th. Zacks Investment Research upgraded shares of CRH Medical Corp from a “hold” rating to a “buy” rating and set a $3.75 price target on the stock in a report on Monday, June 6th.

The company’s 50 day moving average price is $3.14 and its 200 day moving average price is $2.95.

CRH Medical Corporation, formerly Medsurge Medical Products Corp., is a healthcare products and services company. The Company operates through segments, including the sale of medical products and the provision of anesthesia services. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.